You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
| Title |
Family-led rehabilitation after stroke in India: the ATTEND trial, study protocol for a randomized controlled trial
|
|---|---|
| Published in |
Trials, January 2016
|
| DOI | 10.1186/s13063-015-1129-8 |
| Pubmed ID | |
| Authors |
Mohammed Alim, Richard Lindley, Cynthia Felix, Dorcas Beulah Chandramathy Gandhi, Shweta Jain Verma, Deepak Kumar Tugnawat, Anuradha Syrigapu, Craig Stuart Anderson, Ramaprabhu Krishnappa Ramamurthy, Peter Langhorne, Gudlavalleti Venkata Satyanarayana Murthy, Bindiganavale Ramaswamy Shamanna, Maree Lisa Hackett, Pallab Kumar Maulik, Lisa Anne Harvey, Stephen Jan, Hueiming Liu, Marion Walker, Anne Forster, Jeyaraj Durai Pandian |
| Abstract |
Globally, most strokes occur in low- and middle-income countries, such as India, with many affected people having no or limited access to rehabilitation services. Western models of stroke rehabilitation are often unaffordable in many populations but evidence from systematic reviews of stroke unit care and early supported discharge rehabilitation trials suggest that some components might form the basis of affordable interventions in low-resource settings. We describe the background, history and design of the ATTEND trial, a complex intervention centred on family-led stroke rehabilitation in India. The ATTEND trial aims to test the hypothesis that a family-led caregiver-delivered home-based rehabilitation intervention, designed for the Indian context, will reduce the composite poor outcome of death or dependency at 6 months after stroke, in a multicentre, individually randomized controlled trial with blinded outcome assessment, involving 1200 patients across 14 hospital sites in India. The ATTEND trial is testing the effectiveness of a low-cost rehabilitation intervention that could be widely generalizable to other low- and middle-income countries. Clinical Trials Registry-India CTRI/2013/04/003557 . Australian New Zealand Clinical Trials Registry ACTRN12613000078752 . Universal Trial Number U1111-1138-6707. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 20% |
| United States | 1 | 20% |
| India | 1 | 20% |
| Unknown | 2 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 167 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 1 | <1% |
| Unknown | 166 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 26 | 16% |
| Student > Master | 19 | 11% |
| Researcher | 16 | 10% |
| Student > Ph. D. Student | 13 | 8% |
| Student > Postgraduate | 10 | 6% |
| Other | 40 | 24% |
| Unknown | 43 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Nursing and Health Professions | 41 | 25% |
| Medicine and Dentistry | 34 | 20% |
| Unspecified | 10 | 6% |
| Psychology | 9 | 5% |
| Neuroscience | 7 | 4% |
| Other | 15 | 9% |
| Unknown | 51 | 31% |